Track 1: Cancer Science

Cancer Science is an in depth field that deals with cancer analysis and medical aid. Cancer, once thought-about as a deadly wellness, however currently with a development within the cancer analysis things has modified. Thought-about it’s thought-about as a large success as there are unit totally different therapies obtainable currently to treat and diagnose the cancer. The targeted cancer medical aid is one among the best therapies in treating cancer because it involves the treating of the cancer cells by targeting and inhibiting the precise molecules that area unit would like for the growth progression.

• Molecular medication
• Cancer biomarkers
• Cancer medicine

Track 2: Cancer Therapy

Surgery, radiation, drugs, and other therapies are used in cancer treatment to eradicate cancer, reduce cancer, or halt the spread of cancer. There are numerous cancer therapies. You might undergo one treatment or a combination of treatments, depending on your specific circumstance.

However, the majority of patients have a mix of therapies, including as surgery along with chemotherapy and radiation therapy. Drugs are used in chemotherapy to kill cancer cells. radiation treatment High-powered energy beams, such X-rays or protons, are used in radiation therapy to kill cancer cells. Radiation therapy devices can either be implanted inside or outside of your body (external beam radiation).

• Cancer Therapeutics
• Metastatic tumors
• Anti-cancer drugs

Track 3: Cancer Metastasis

The unfold of cancer from one half of} the body to a different part or to the body fluid nodes, that don't seem to be stream or the body fluid system and it chiefly affects brain, liver, lungs and bones. The pathological process cancer cells doesn't match the feature of the cells wherever it had been found however it resembles the first cancer cells that is taken into account as a next stage of the first cancer cells. All pathological process cancers square measure thought-about as advanced cancers. Directly joined to every alternative, is termed cancer metastasis. Cancer is taken into account as a deadly wellness chiefly due to its ability to unfold within the body. This metastasis takes place through the blood

Track 4: Radiation Oncology

The usage of ionizing radiation in the cancer treatment is known as radiation oncology. Mostly the chemotherapy and radiation therapy are used in combination to treat tumor. It also helps better to reduce the tumor burden. The radiation therapy has some side effects, they are categorized into immediate and late side effects. The prompt reactions are retching, intestinal uneasiness, swelling, infertility and so forth., The late symptoms are fibrosis, epilation, heart infections and so on., Sometimes radiation enteropathy will likewise involvement by the patients.

Track 5: Cancer Immunology & Immunotherapy

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumours or malignancies). It is a field of research that aims to discover cancer immunotherapies to treat and retard progression of the disease. Cancer immunotherapy also known as Immuno-oncology is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). The immune response, including the recognition of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumour marker-based diagnostic tests.

 Track 6: Cancer Pharmacology

Pharmacology manages activity of medication in the body. Medications demonstrated great outcomes in creature show, when utilized as a part of cancer patient of less tumor trouble was not all that powerful. In such case the tumor burden can be reduced first by cancer surgery and it is followed by chemotherapy can be done, this is called as adjuvant therapy. In combination with chemotherapy, a heat therapy called hyperthermia therapy can be used to control various cancer types. The electric volts are passed on the tumor cells to stop their movement alongside chemotherapy is known as electrochemotherapy. The use of chemotherapy alone for cancer treatments leads to many side effects like cardiotoxicity, nephrotoxicity, ototoxicity etc., Cancer genetics will be helpful for identifying the mode of treatment for Cancer. Cancer biomarkers adequately help with discovering tumor cells and treating them. Cancer Conferences gives a discernment about the new methodologies rising in malignancy treatment.

Track 7: Cancer Nanotechnology

Nanotechnology offers scientists with the chance to examine and control macromolecules progressively and amid the most punctual phases of malignancy movement. It gives the way to target chemotherapies specifically and specifically to carcinogenic cells and neoplasms, impact in careful resection of tumors, and improve the restorative adequacy of radiation-based and other current treatment modalities. Nanotechnology can give quick and unpretentious location of tumor related particles, empowering researchers to identify sub-atomic changes not withstanding when they happen just in a little level of cells. Nanotechnology likewise can possibly induce totally novel and exceedingly therapeutic agents.

Track 8: Cancer Genetics

Cancer is a hereditary infection created by increment of DNA transformations and epigenetic changes that prompts uncontrolled cell multiplication and neoplasm arrangement. Transformation happens as often as possible in the collection of human still it can ready to adjust the greater part of the changes. Along these lines, it won't be conceivable to cause tumor with one transformation. For the most part, it takes various changes in a lifetime of a human to cause disease. This is the reason senior individuals have malignancy, as they have had various possibilities for transformation. Oncogenomic manages the portrayal of cancer related qualities. Tumour suppressor genes or oncogenes are the one that deals with the cell cycle process, so they are known as the protective cells. These hereditary changes heighten the danger of malignancy. The nearness of changed qualities in germ cells can be acquired to the off springs. Tumor Pharmacology manages the activity of medication on disease patients. Cancer science Meetings investigates the new thoughts and systems of malignancy treatment.

Track 9: Cancer Cell Biology

Cancer cells have the ability to partition in a wild way. Disease cells overlook flags that will be dynamic in keeping the cell division, apoptosis and cell shedding. In a cancer cell, the greater part of the qualities transform into a flawed one. Malignant tumors can spread into, or attack, close-by tissues so they are the reason for growth. By the movement of these tumors, some growth cells can be part and travel to different parts in the body through the plasma or the lymphatic system and structures another tumor cell far from the first tumor which is called metastasis. Cancer pathogenesis manages the sub-atomic, biochemical, and cell-based methodologies are incorporated into growth cell science to all the more likely get it. Cancer Genetics manages the disease development because of hereditary changes, if the progressions are available in germ cells it can be acquired from guardians to off-springs. Tumor Immunology assumes an imperative part in choice of new methodologies for cancer therapeutics. Tumor Science Conferences explain the advancements in the cancer science field.

Track 10: Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Stem Cells and Tumours cancer cells also have the characteristic which is also associated with normal stems cells. Stem Cell Therapy is using to prevent the disease. Stems cells transplant is used to treatment of cancer like leukaemia, multiple myeloma & lymphoma. Cord Blood Stem and Cancer cord blood contains haematopoietic (blood) stem cell. They have long been used in stem cell treatments for leukaemia, blood and bone marrow disorders when chemotherapy is used.

Track 11: Cancer Epidemiology

Cancer Epidemiology includes the study of the factors affecting cancer, to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments. It can be used to identify events that increase or decrease cancer incidence in specific populations. The studies related to population-based research on cancer ethology, prevention, surveillance and survivorship, analytical, and molecular epidemiology, survivorship studies, risk factors, as well as the role of behavioural factors in cancer ethology and prevention are also included.

Track 12: Cancer Biomarkers

The Cancer Biomarkers are the substances that go about as a marker of the cancer site in the body. Typically, the biomarker is a processable marker of natural state in the body, it is an atom which is released by the tumor or because of the nearness of tumor. The biomarkers are utilized for the evaluation of hazard for disease patients. The cancer biomarkers particularly related to hereditary changes or epigenetic modification dependably gives the quantifiable method to discover the tumor cells. The most worthwhile capacity of biomarker is that they can be utilized as a symptomatic instrument, decides if the tumor is confined or metastatic in nature. The cancer prognosis can likewise be controlled by the biomarkers.

Track 13: Cancer Biopsy

A biopsy is a restorative examination normally done by a specialist, an interventional radiologist, or an interventional cardiologist concerning extraction of test cells or tissues for investigation to decide the presence of a malady state. Predominantly the biopsy is of two classifications, the excisional biopsy in which the influenced tissues or cells are expelled and the incisional biopsy in which some example is separated from the influenced locale for analysis. At the point when disease is suspected, the primary endeavor will be excisional biopsy on the off chance that it doesn't work they will go for incisional biopsy to decide if the tumor is generous or harmful. Some of the time in biopsy if the zone of doubt isn't discovered, X-beams or ultrasound can be utilized to follow the territory it is known as ultra sound guided biopsy or stereotactic guided biopsy.

Track 14: Cancer Diagnosis and Screening

Screening tests can help to find cancer at an early stage, before recognizing the symptoms. Diagnostic testing of cancer includes the tests done by a pathologist to confirm the stage of cancer, size of the tumor, area infected by the tumor, etc.  Various pathological and histopathological techniques are used in cancer diagnosis. Some of the common procedures for Cancer diagnosis are biopsy, MRI, X-Ray etc. A portion of alternate strategies which are ordinarily utilized these days to distinguish or recognize the tumors beginning from an organ are endoscopy for gastrointestinal diseases, mammography for breast cancers and so on. One of the newly invented techniques for detection of organ defined cancers is nuclear medicine imaging which utilizes radiopharmaceuticals to identify the structure of the tumor present in that specified organ or tissue. Cancer Conferences gives a platform to present the novel treatments for cancer.

Track 15: Cancer Metabolomics

Cancer genomics deals with the characterization difference between the cancer cells and normal cells based on gene expression and sequence of the DNA. The purpose of this study is to understand the basic genetics of tumor progression, development of genome of cancer by mutation and the action of drug in the cancer micro environment.  Metabolomics is the study of the chemical fingerprints left by a metabolite during metabolism. In case of cancer cells, it will be very useful to study the metabolite profile for drug development. Many discoveries are being made in cancer metabolomics, one of them is the noninvasive validation of metabolic biomarkers from the body fluid of cancer patients. Cancer Cell Biology makes the better understanding of the chemical changes happening inside cancer cells. Cancer Science Conferences provides a multidisciplinary knowledge to cancer researchers.

Track 16: Cancer Management and Prevention

The tumor avoidance is chiefly to decrease the danger of getting cancer. There are numerous variables that we need to consider to counteract tumor, they are having a sound existence style, staying away from the cancer-causing agents and related substances, expending malignancy immunizations that forestall disease. The malignancy management should be possible by numerous routes relying on the phase of the disease. The growth medical procedure is the best alternative in the beginning time. Aside from medical procedure there are numerous treatments to deal with the growth. The immunotherapy that aides in fortifying the safe framework to treat growth. A few people will likewise go for elective medication. The exactness treatments or the accuracy meds can likewise be utilized to treat disease. Inspite of all treatment and administration, in last phases of disease just the palliative care can be given to the patients to comfort them. Disease Science and Therapy Conferences uncovers the contemporary changes in cancer field.

Track 17: Cancer: Alternative Medicine

The alternative medicine for cancer is something which is given for the cancer patients as an alternate to the existing therapies, which are not proved by the Food and Drug Administration - FDA. The Massage therapy have showed some good results but they are only temporary. Other therapies like supportive psychotherapy and hypnosis shows very weak results. The Cognitive treatment demonstrated direct advantages yet again it is additionally transitory. The suggestion for Music therapy is ambiguous, and certain herbal interferences are very poisonous to some cancer patients. The Acupuncture Treatment is also being predominantly used alternative treatments, but with very weak results. All these treatments will give only placebo effects, nothing more than that for cancer therapy. Cancer Science Conferences serves to investigations the simultaneous routes in growth treatment.

ME Conferences invite all the participants through the world to affix at 36th International Conference on Cancer Science & Therapy that goes to be scheduled on December 12-13, 2022 Stockholm, Sweden which is able to embrace keynote shows, Oral talks, Poster shows, and Exhibitions. Cancer Science Congress 2022 may be a specially designed cluster conference. The most focus of the conference is “Bridging excellence within the field of Cancer science” that covers a large vary of critically necessary sessions. The conference is CME & CPD commissioned.

For More details please visit: https://cancerscience.cancersummit.org/

Importance & Scope

Cancer is the second leading cause of death worldwide. It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. And only a global search for answers will help us get to grips with this disease. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology.

CANCER SCIENCE CONGRESS 2022 will also explore the new ideas and concepts on global scale and the topics Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Tumor Virology, Cancer Nanotechnology, Cancer Treatment & Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Frontiers in Cancer Science, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.

Market Analysis Report:

Cancer is a disease characterized by the abandoned growth and spread of abnormal cells. If the growth of abnormal cells is not controlled, it can result in death. In Worldwide, one in seven deaths is due to cancer.  cancer causes more deaths than AIDS, tuberculosis, and malaria. According to income when countries are grouped, cancer is the second leading cause of death in high-income countries (following cardiovascular diseases) and the third leading cause of death in low- and middle-income countries (following cardiovascular diseases and infectious and parasitic diseases).

Cancer Diagnostics Market:

The global market size of cancer diagnostics is expected to reach $22.7 billion from $7.1 billion in 2015. Growing prevalence of oncologic cases, constant technological innovations in diagnostics, and increasing requirement for effective screening tests are some of the main factors prompting the demand for screening tools across the world.

Rising awareness and supportive government enterprises are some other factors that are anticipated to increase the growth of the sector during the forecast period. The global cancer diagnostics market is fragmented based on technology, application, and region.  Increase in aging population and cancer cases are likely to create a huge opportunity for cancer diagnostics.

Cancer Diagnostic Market, By Technology

 Based on technology, the cancer diagnostics market is divided into instrument-based and platform-based. In 2015, the instrument-based segment is predicted to account for a major share of the cancer diagnostics market, by product.

1) Platform Based:

• In situ Hybridization
• Flow Cytometry
• Next-generation Sequencing
• Microarrays
• Others

2) Instrument Based:

• Biopsy
• Mammography
• PET
• Ultrasound
• MRI
• CT

Cancer Diagnostic Market, By Region

Based on region, the cancer diagnostics market is classified into North America, Europe, Asia, and Rest of the World. Rest of the World includes Latin America, Pacific countries, and Middle East and Africa. North America is predicted as the largest share in the cancer diagnostics market, followed by Europe and Asia.

Some of the major performers in the global cancer diagnostics system market are:

• Sanofi (France)
• Novartis (Germany)
• Pfizer Inc. (U.S.)
• Eli Lilly & Company (U.S.)
• ImClone Systems Inc. (U.S.)
• GlaxoSmithKline (U.K)
• AstraZeneca (U.K)
• Schering-Plough (U.S.)
• Boehringer Ingelheim (Germany)
• Bristol-Myers Squibb
• Teva Pharmaceuticals Industries (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Merck & Co., Inc. (U.S.)
• Chemo Espana SL (Spain)
• CELGENE CORPORATION (U.S.)
• Amgen Inc (U.S.)
• Bayer AG (Germany)
• Takeda Pharmaceutical Company Limited (Japan)

Major Medical Universities

Worldwide

• Harvard University
• University of Minnesota
• Mayo Medical School
• Pittsburgh School of Medicine
• Yale University
• University of Cambridge
• University of Oxford Stanford University
• Yale University
• Emory University
• John Hopkins University
• Kings College London
• Feinberg School of Medicine
• University of Wisconsin
• UNC School of Medicine
• Karolinska University

Major Associations

Worldwide

• American Association for Cancer Research
• Virginia Cancer Institute
• American Brain Tumor Association
• American Society of Paediatric Haematology/Oncology
• Association of Cancer Physicians
• American Childhood Cancer Organization
• American Society of Clinical Oncology
• Australasian Lung Cancer Trials Group
• International Cancer Research Partnership (ICRP)
• American Association for Cancer Research (AACR)
• American Society of Clinical Oncology (ASCO)
• International Agency for Research on Cancer (IARC)
• Cancer Society of New Zealand
• Irish Cancer Society
• Australian Cervical Cancer Foundation
• Medical Centre Cologne
• Cancer Research UK
• Australian Prostate Cancer Research
• Peter McCollum Cancer Centre
• The European Cancer Organization (ECCO)
• German Cancer Research Centre